Pliant Therapeutics has discontinued a pivotal Phase 2b/3 clinical trial evaluating bexotegrast as an IPF treatment.
HealthDay News — For patients with chronic liver disease, statin use is associated with a reduced risk for hepatocellular carcinoma (HCC) and hepatic decompensation, according to a study published ...
Discover why Gyre Therapeutics is rated 'Hold' amid volatile stock behavior, uncertain long-term prospects, and pending Phase ...
John and his wife, Rachel Meadows, are sharing more about their search. The happy couple has twin 3-year-old boys, they say ...
An Ormond Beach woman has been caring for animals often left for dead. Dawn Barbone is the Founder and CEO of Samadhi Wildlife. “This is Faithy! Come on baby eat your food now,” Barbone said. Faithy ...
Although cystic fibrosis is a single gene mutation, there are more than 1,000 different ways the CFTR gene can mutate in ...
The Foundation’s National Volunteer Advocacy Committee provides guidance and support to further strengthen and enhance the ...
Machine learning may help identify biomarkers and develop predictive models that could assist in the diagnosis of metabolic ...
Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, ...
Phase 1 MAD dosing completed for SION-451 and final MAD cohort of SION-719 planned; Interim data in healthy volunteers show potential to provide ...
Heavy alcohol use is taking an earlier toll, landing more young Americans onto transplant lists. The obesity epidemic makes ...